- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 19 December 2018
-
Current Status:
Taken in the Chamber on 9 January 2019
To ask the Scottish Government how many of the 38,000 people that Fair Start Scotland aims to support it expects to participate in each year to 2020.
Answer
Taken in the Chamber on 9 January 2019
- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 21 November 2018
-
Current Status:
Answered by Michael Matheson on 6 December 2018
To ask the Scottish Government what discussions it has had with (a) VisitScotland and (b) Transport Scotland regarding the potential for cycle tourism at the proposed Maybole bypass.
Answer
In developing the scheme, consultation on active travel was undertaken with stakeholders including South Ayrshire Council, Cycling Touring Club Scotland, Sustrans, British Horse Society (BHS); and Scotways.
As an Agency of the Scottish Government, there are regular discussions with Transport Scotland about the full range of areas for which it has responsibility.
- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 05 December 2018
-
Current Status:
Taken in the Chamber on 12 December 2018
To ask the Scottish Government what it is doing to ensure that sport and physical activity are available to all, irrespective of background or personal circumstances.
Answer
Taken in the Chamber on 12 December 2018
- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 21 November 2018
-
Current Status:
Taken in the Chamber on 28 November 2018
To ask the Scottish Government what action it is taking to boost tourism in rural areas through the promotion of industrial heritage sites.
Answer
Taken in the Chamber on 28 November 2018
- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Friday, 26 October 2018
-
Current Status:
Answered by Jeane Freeman on 20 November 2018
To ask the Scottish Government what its response is to reports from clinicians that accessing the drug, Orkambi, by people with cystic fibrosis, is time consuming, and leads to inequitable access for patients, and what action it can take to simplify the process.
Answer
The Scottish Government has undertaken to review the Peer Approved Clinical System (PACS) Tier Two six and twelve months after it commenced on 1 June 2018. As part of those reviews we will expect to receive feedback from Health Boards and clinicians.
PACS Tier Two allows clinicians to apply for individual patient access to medicines which would otherwise be routinely unavailable to them, such as Orkambi. We strongly encourage clinicians to make use of this system if they judge a medicine as appropriate for their individual patient’s needs. Importantly, the cost of the medicine is not a decision-making criterion in this process and there is no requirement to demonstrate patient exceptionality compared to the patient population.
- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 07 November 2018
-
Current Status:
Taken in the Chamber on 14 November 2018
To ask the Scottish Government what it is doing to ensure that farmers have access to public procurement contracts for food.
Answer
Taken in the Chamber on 14 November 2018
- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 05 November 2018
-
Current Status:
Taken in the Chamber on 8 November 2018
To ask the First Minister, in light of the study, Defying Arthritis at Every Age, what the Scottish Government is doing to reduce loneliness and isolation among people with the condition.
Answer
Taken in the Chamber on 8 November 2018
- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Friday, 26 October 2018
-
Current Status:
Answered by Jeane Freeman on 2 November 2018
To ask the Scottish Government whether it is considering giving the cystic fibrosis drug, Orkambi, ultra orphan status, and, if so, when it will publish its findings.
Answer
I refer the member to the answer to question S5W-19167 on 29 October 2018. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at:
http://www.parliament.scot/parliamentarybusiness/28877.aspx
- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Friday, 26 October 2018
-
Current Status:
Answered by Jeane Freeman on 2 November 2018
To ask the Scottish Government, further to the answers to questions S5W-18944 and S5W-19151 by Jeane Freeman on 27 September and 4 October 2018 respectively, how many people have accessed the cystic fibrosis drug, Orkambi, through the Peer Approved Clinical System (PACS) Tier Two Panel.
Answer
There were six requests for Orkambi through the Peer Approved Clinical System (PACS) Tier Two process between 1 June 2018 and 31 September 2018. Four of these were accepted and two decisions were deferred by the relevant Health Boards for further consideration.
- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 31 October 2018
-
Current Status:
Taken in the Chamber on 8 November 2018
To ask the Scottish Government when the findings of the South West Transport Study will be published.
Answer
Taken in the Chamber on 8 November 2018